Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics, Inc. (LXEO) Depreciation & Amortization (CF) (2022 - 2023)

Lexeo Therapeutics' Depreciation & Amortization (CF) history spans 2 years, with the latest figure at $77000.0 for Q4 2023.

  • For Q4 2023, Depreciation & Amortization (CF) rose 32.76% year-over-year to $77000.0; the TTM value through Dec 2023 reached $271000.0, changed N/A, while the annual FY2024 figure was $304000.0, 12.18% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2023 was $77000.0 at Lexeo Therapeutics, down from $78000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $78000.0 in Q3 2023 and bottomed at $57000.0 in Q1 2023.